• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Mergers and Acquisitions in the IVD Market, October 2015

$499.00 – $1,000.00

Clear
SKU: KLI5722029 Categories: Diagnostics Market Research, Oncology & Hematology Market Reports, Point-of-Care Diagnostics Pages: 60
  • Description
  • Table of Contents
  • Latest reports

Description

Mergers and Acquisitions in the IVD Market

Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market.

An IVD firm generally acquires another company to do one or more of the following:

  • acquire a new IVD technology
  • enter a new segment of the IVD market
  • counter a competitor
  • open a distribution channel

Mergers may or may not prove to be profitable, and the successful integration of companies can often prove time-consuming. The return on these investments might fluctuate due to a number of market drivers and constraints, including future performance, lawsuits, market valuations, and the arrival of newer technologies. Many top tier IVD companies are often willing and able to assume the risks involved in acquisitions and have recently struck deals.

Mergers and Acquisitions in the IVD Market discusses particular market segments that have proven active with respect to mergers and acquisitions, including the cancer, molecular, tissue and cell, companion, and point of care (POC) diagnostic market segments.

As an industry, the goal is to move beyond interoperability challenges and refocus energy on advancing healthcare. Next steps include the creation of the coming generation of IVD products, which will integrate the clinical lab into the mainstream of healthcare information flow.

The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.

Table of Contents

ONE: EXECUTIVE SUMMARY

Introduction

Methodology

TWO: IVD MERGERS AND ACQUISITIONS

Introduction

Select Top Tier IVD Company Acquisitions

Roche

Abbott Diagnostics

Siemens

Johnson and Johnson (J&J)

Beckman Coulter/Danaher

Thermo Fisher

Alere

BD (Becton, Dickinson and Company)

bioMérieux

Bio-Rad Laboratories

Arkray

QIAGEN

Hologic

Select Acquisitions in 2014 and 2015

Acquisitions Activity in Selected IVD Market Segments

Cancer Diagnostics

Molecular Diagnostics

Tissue and Cell Diagnostics

Companion Diagnostics

Point of Care (POC)

Selected Information Technology (IT) Company Activities

Select Acquisitions in 2012 and 2013

LIST OF EXHIBITS

TWO: IVD MERGERS AND ACQUISITIONS

Table 2-1: Selected Acquisitions of Diagnostic Companies, 2014-2015

Table 2-2: Selected Acquisitions of Diagnostic Companies, 2012-2013

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats, Volumes I – III

    $3,995.00 – $7,990.00
  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    Cell-Based Diagnostics: Technology, Applications, and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Clinical Laboratory Services Market: Forecasts to 2020The World Market for Infectious Disease Diagnostic Tests
Scroll to top